[HTML][HTML] Podophyllotoxin and its derivatives: Potential anticancer agents of natural origin in cancer chemotherapy
S Motyka, K Jafernik, H Ekiert, J Sharifi-Rad… - Biomedicine & …, 2023 - Elsevier
The use of plant secondary metabolites has gained considerable attention among clinicians
in the prevention and treatment of cancer. A secondary metabolite isolated mainly from the …
in the prevention and treatment of cancer. A secondary metabolite isolated mainly from the …
The potential role of miRNAs in the pathogenesis of adrenocortical carcinoma-A focus on signaling pathways interplay
Adrenocortical carcinoma (ACC) is a highly malignant infrequent tumor with a dismal
prognosis. microRNAs (miRNAs, miRs) are crucial in post-transcriptional gene expression …
prognosis. microRNAs (miRNAs, miRs) are crucial in post-transcriptional gene expression …
Natural polyphenols as modulators of etoposide anti-cancer activity
M Kluska, K Woźniak - International journal of molecular sciences, 2021 - mdpi.com
Polyphenols are naturally occurring compounds found in abundance in fruits and
vegetables. Their health-promoting properties and their use in the prevention and treatment …
vegetables. Their health-promoting properties and their use in the prevention and treatment …
Cushing's syndrome effects on the thyroid
RM Paragliola, A Corsello, G Papi… - International journal of …, 2021 - mdpi.com
The most known effects of endogenous Cushing's syndrome are the phenotypic changes
and metabolic consequences. However, hypercortisolism can exert important effects on …
and metabolic consequences. However, hypercortisolism can exert important effects on …
Etoposide triggers cellular senescence by inducing multiple centrosomes and primary cilia in adrenocortical tumor cells
YN Teng, HC Chang, YY Chao, HL Cheng, WC Lien… - Cells, 2021 - mdpi.com
Etoposide (ETO) has been used in treating adrenocortical tumor (ACT) cells. Our previous
study showed that ETO inhibits ACT cell growth. In the present study, we show that ETO …
study showed that ETO inhibits ACT cell growth. In the present study, we show that ETO …
Management of adrenocortical carcinoma: are we making progress?
B Kiesewetter, P Riss, C Scheuba… - Therapeutic …, 2021 - journals.sagepub.com
Adrenocortical carcinoma (ACC) is a rare malignancy characterized by aggressive biology
and potential endocrine activity. Surgery can offer cure for localized disease but more than …
and potential endocrine activity. Surgery can offer cure for localized disease but more than …
What is the optimal duration of adjuvant mitotane therapy in adrenocortical carcinoma? An unanswered question
A relevant issue on the treatment of adrenocortical carcinoma (ACC) concerns the optimal
duration of adjuvant mitotane treatment. We tried to address this question, assessing …
duration of adjuvant mitotane treatment. We tried to address this question, assessing …
Design of molecularly imprinted polymer materials relying on hydrophobic interactions
N Jaoued-Grayaa, C Nasraoui, Y Chevalier… - Colloids and Surfaces A …, 2022 - Elsevier
The design of molecularly imprinted polymers (MIPs) for the specific binding of hydrophobic
molecules (mitotane) was investigated by considering monomers and cross-linking agents …
molecules (mitotane) was investigated by considering monomers and cross-linking agents …
The use of African medicinal plants in cancer management
G Gaobotse, S Venkataraman, PD Brown… - Frontiers in …, 2023 - frontiersin.org
Cancer is the third leading cause of premature death in sub-Saharan Africa. Cervical cancer
has the highest number of incidences in sub-Saharan Africa due to high HIV prevalence …
has the highest number of incidences in sub-Saharan Africa due to high HIV prevalence …
Adrenocortical Carcinoma: Role of Adjuvant and Neoadjuvant Therapy.
L Kenney, M Hughes - Surgical Oncology Clinics of North America, 2023 - europepmc.org
Adjuvant and neoadjuvant chemotherapy in the treatment of adrenocortical carcinoma
(ACC) is limited by few existing trials, most of which are retrospective. The drug mitotane has …
(ACC) is limited by few existing trials, most of which are retrospective. The drug mitotane has …